bismuth subcitrate, tetracycline and metronidazole

North America

Canada (0)
No result.
United States (0)
No result.

Europe

Austria (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PYLERA 140 MG/125 MG/125 MG caps, hard
Rx
-
A02BD08
PYLERA 140 MG/125 MG/125 MG caps, hard
Rx
-
A02BD08
PYLERA 140 MG/125 MG/125 MG caps, hard
Rx
-
A02BD08
PYLERA 140 MG/125 MG/125 MG caps, hard
Rx
-
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PYLERA 140 MG/125 MG/125 MG caps, hard
135697
12-08-2014
PYLERA 140 MG/125 MG/125 MG caps, hard
135697-P3
15-07-2020
PYLERA 140 MG/125 MG/125 MG caps, hard
135697-P1
03-08-2018
PYLERA 140 MG/125 MG/125 MG caps, hard
135697-P2
10-01-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TRYPLERA 140 MG - 125 MG - 125 MG caps, hard
120x
Y
oral
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TRYPLERA 140 MG - 125 MG - 125 MG caps, hard
120x
BE405666
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
TRYPLERA 140 MG - 125 MG - 125 MG caps, hard
120x
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PYLERA 140MG/125MG/125MG caps, hard
140MG/125MG/125MG 120
N
oral
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PYLERA 140MG/125MG/125MG caps, hard
140MG/125MG/125MG 120
09/ 248/14-C
MRP/DCP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
PYLERA 140MG/125MG/125MG caps, hard
140MG/125MG/125MG 120
1173,1
1601,08
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PYLERA 140 MG + 125 MG + 125 MG caps, hard
120 caps
-
Rx
-
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PYLERA 140 MG + 125 MG + 125 MG caps, hard
120 caps
19518
DCP
Product
Pack
SPC
PIL
Company
PYLERA 140 MG + 125 MG + 125 MG caps, hard
120 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (0)
No result.
Slovenia (0)
No result.
Spain (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PYLERA 140 MG/125 MG/125 MG caps, hard
120 caps
Y
Rx
oral
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PYLERA 140 MG/125 MG/125 MG caps, hard
120 caps
75095
16-04-2012
Product
Pack
SPC
PIL
Company
PYLERA 140 MG/125 MG/125 MG caps, hard
120 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (0)
No result.
Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PYLERA caps, hard
-
A
-
A02BD08
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PYLERA caps, hard
66366 1
Hauptzulassung
30-11-2017
29-11-2022
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.